Krista M. Isaac

Krista M. Isaac

Hematology | Oncology

1203 Langhorne-Newtown Road
Suite 135
Langhorne, PA 19047

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.

Journal: Haematologica

Published: April 07, 2023

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.

Journal: Blood advances

Published: September 09, 2022

PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis.

PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis.

Journal: The Journal of clinical investigation

Published: October 26, 2021

Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.

Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.

Journal: Current oncology reports

Published: May 20, 2021

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.

Journal: Blood

Published: March 24, 2021

Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.

Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.

Journal: Blood advances

Published: March 17, 2021

Extrinsic interactions in the microenvironment in vivo activate an antiapoptotic multidrug-resistant phenotype in CLL.

Extrinsic interactions in the microenvironment in vivo activate an antiapoptotic multidrug-resistant phenotype in CLL.

Journal: Blood advances

Published: December 02, 2020

Epidemiology of acute myeloid leukemia in Virginia: Excellent survival outcomes for patients in rural Appalachia.

Epidemiology of acute myeloid leukemia in Virginia: Excellent survival outcomes for patients in rural Appalachia.

Journal: Cancer reports (Hoboken, N.J.)

Published: September 19, 2020

Outcomes of COVID-19 in patients with CLL: a multicenter international experience.

Outcomes of COVID-19 in patients with CLL: a multicenter international experience.

Journal: Blood

Published: May 13, 2020

Acalabrutinib and Its Therapeutic Potential in the Treatment of Chronic Lymphocytic Leukemia: A Short Review on Emerging Data.

Acalabrutinib and Its Therapeutic Potential in the Treatment of Chronic Lymphocytic Leukemia: A Short Review on Emerging Data.

Journal: Cancer management and research

Published: December 04, 2019

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 23, 2019

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.

Journal: Haematologica

Published: March 17, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026